Search - tctmd.com

Displaying 41 - 60 of 149

Sort: Relevancy | Date

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

Presentation Live Valves 2019

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

Presenter: Danny Dvir

December 10, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

Advertisement

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Device Explants After TAVR Rare but Risky

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Newer TAVR Devices Reassure in Failed Surgical Valves

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

TCT 2019 Day Two: Transcatheter Valves, New and Old

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content